首页> 美国卫生研究院文献>Bioinformation >Molecular docking based screening of triterpenoids as potential G-quadruplex stabilizing ligands with anti-cancer activity
【2h】

Molecular docking based screening of triterpenoids as potential G-quadruplex stabilizing ligands with anti-cancer activity

机译:基于分子对接的三萜类化合物作为具有抗癌活性的潜在G-四链体稳定配体的筛选

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Triterpenoids isolated from Ganoderma lucidum (GLTs) exhibit a broad spectrum of anti-cancer properties, including anti-proliferative, anti-metastatic and anti-angiogenic activities. Current research studies revealed the role by GLTs in inducing apoptosis and suppression of telomerase activity of cancer cells with much lower toxicity to healthy cells. Compounds selectively binding and stabilizing G-quadruplex structures could inhibit the telomerase or downregulate the oncogenes and may act as anti-cancer agents. Targeting human telomeric G-quadruplex DNA could be one of the mechanisms by which these GLTs exert anti-cancer activity. In this study, 208 GLTs were screened for ligands with high binding affinity and selectively to stabilize the pG4DNA by using the docking tool AutoDock4. The results showed that ganoderic acid A and ganoderic acid Df exhibit high binding affinity and selectively bind to the lateral groove of pG4DNA. Based on our findings, we suggest that the triterpenoid represents a new class of G-quadruplex groove binding ligands and thus act as potential anti-cancer agents.
机译:从灵芝(GLT)分离出的三萜类化合物具有广泛的抗癌特性,包括抗增殖,抗转移和抗血管生成活性。当前的研究表明,GLTs可以诱导癌细胞的凋亡和抑制端粒酶活性,而对健康细胞的毒性要低得多。选择性结合和稳定G-四链体结构的化合物可抑制端粒酶或下调癌基因,并可作为抗癌药。靶向人类端粒G-四链体DNA可能是这些GLT发挥抗癌活性的机制之一。在这项研究中,筛选了208个GLT,筛选具有高结合亲和力的配体,并使用对接工具AutoDock4选择性地稳定pG4DNA。结果表明,灵芝酸A和灵芝酸Df表现出高结合亲和力并选择性地结合到pG4DNA的侧向沟纹上。根据我们的发现,我们建议三萜代表一种新型的G-四链体沟结合配体,因此可作为潜在的抗癌药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号